Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer’s and Multiple Sclerosis

May 13, 2014 Inovio Pharmaceuticals, Inc. announced today it acquired worldwide rights (excluding China) for early preclinical therapies addressing Alzheimer’s disease and multiple sclerosis based on the academic research of Dr. Bin Wang, a professor at Fudan University’s Shanghai Medical College. Dr. Wang is a pioneer in the field of DNA therapies, having worked closely with Dr.David Weiner at the University of Pennsylvania. …